Fundraising September 15, 2024 – October 1, 2024 About fundraising

Volume 29; Issue 12

Main
PharmacoEconomics
Volume 29; Issue 12

PharmacoEconomics

Volume 29; Issue 12

1

Cost Effectiveness of Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B from a Canadian Public Payer Perspective

Dakin, Helen, Sherman, Morris, Fung, Scott, Fidler, Carrie, Bentley, Anthony

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 226 KB

english, 2011

2

Cost-Effectiveness Analysis of Prophylactic Lamivudine Use in Preventing Vertical Transmission of Hepatitis B Virus Infection

Hui-Fang Hung,Professor Hsiu-Hsi Chen

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 164 KB

english, 2011

3

Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease

Judith Dams,Bernhard Bornschein,Jens Peter Reese…

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 244 KB

english, 2011

4

Erlotinib Monotherapy for the Maintenance Treatment of Non-Small Cell Lung Cancer after Previous Platinum-Containing Chemotherapy

Ms Rumona Dickson,Adrian Bagust,Angela Boland,Michaela Blundell…

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 158 KB

english, 2011

5

QALYs and Carers

Dr Hareth Al-Janabi,Terry N. Flynn,Joanna Coast

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 125 KB

english, 2011

6

Erratum to: The cost effectiveness of rufinamide in the treatment of Lennox-Gastaut syndrome in the UK

Á Benedict,L Verdian,G Maclaine

Journal:

PharmacoEconomics

Year:

2011

File:

PDF, 41 KB

2011

7

Acknowledgment

Journal:

PharmacoEconomics

Year:

2011

Language:

english

File:

PDF, 64 KB

english, 2011